P35-1 ED in Metastatic PC Patients Treated with ADT
Learn about the prevalence of Erectile dysfunction in patients with metastatic PC treated with androgen-deprivation therapy and how the severity of ED varies depending on the type of ADT used.
Stay updated with breaking news from Erectile Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Learn about the prevalence of Erectile dysfunction in patients with metastatic PC treated with androgen-deprivation therapy and how the severity of ED varies depending on the type of ADT used.
A recent study reported that COVID-19 vaccination does not elevate the risk of erectile dysfunction.
Data Published in the "International Journal of Urology" Also Showed Secondary Endpoints, Such as Onset of action in 15 Minutes and Percentage of Patients Reaching Normal Erectile Function According to
In a recent study, researchers assessed male reproductive health three months after COVID-19 infection.
This is the first randomized controlled trial of low-intensity shock wave therapy in men with vasculogenic erectile dysfunction.